Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison D Grant

Showing results (31-40 of 180) with videos related to

Pageof 18
Sort By:
Plos One|June 6, 2012
Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcomeVictoria Johnston, Katherine Fielding, Salome Charalambous, et al.
BMC Health Services Research|March 20, 2022
Barriers to tuberculosis case finding in primary and secondary health facilities in Ghana: perceptions, experiences and practices of healthcare workersJoyce B Der, Alison D Grant, Daniel Grint, et al.
Sexually Transmitted Infections|February 21, 2012
Prevention of mother-to-child transmission of HIV: assessing the accuracy of routinely collected data on maternal antiretroviral prophylaxis coverage in KenyaLaura Ferguson, Alison D Grant, John O Ong'ech, et al.
BMC Public Health|February 20, 2008
"That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programmeMison Dahab, Salome Charalambous, Robin Hamilton, et al.
Plos One|May 22, 2013
Comparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort studyKavindhran Velen, James J Lewis, Salome Charalambous, et al.
The Journal of Infectious Diseases|November 8, 2017
Designing and Evaluating Interventions to Halt the Transmission of TuberculosisDavid W Dowdy, Alison D Grant, Keertan Dheda, et al.
AIDS (London, England)|November 17, 2010
Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative studyRebecca Lester, Robin Hamilton, Salome Charalambous, et al.
Tropical Medicine & International Health : TM & IH|March 8, 2012
Linking women who test HIV-positive in pregnancy-related services to long-term HIV care and treatment services: a systematic reviewLaura Ferguson, Alison D Grant, Deborah Watson-Jones, et al.
American Journal of Epidemiology|December 19, 2017
Impact of Targeted Tuberculosis Vaccination Among a Mining Population in South Africa: A Model-Based StudySourya Shrestha, Violet Chihota, Richard G White, et al.
Tropical Medicine & International Health : TM & IH|March 4, 2014
Durable HIV RNA resuppression after virologic failure while remaining on a first-line regimen: a cohort studyChristopher J Hoffmann, Salome Charalambous, Alison D Grant, et al.
Pageof 18

Showing results (31-40 of 180) with videos related to

Sort By:
Pageof 18
Plos One|June 6, 2012
Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcomeVictoria Johnston, Katherine Fielding, Salome Charalambous, et al.
BMC Health Services Research|March 20, 2022
Barriers to tuberculosis case finding in primary and secondary health facilities in Ghana: perceptions, experiences and practices of healthcare workersJoyce B Der, Alison D Grant, Daniel Grint, et al.
Sexually Transmitted Infections|February 21, 2012
Prevention of mother-to-child transmission of HIV: assessing the accuracy of routinely collected data on maternal antiretroviral prophylaxis coverage in KenyaLaura Ferguson, Alison D Grant, John O Ong'ech, et al.
BMC Public Health|February 20, 2008
"That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programmeMison Dahab, Salome Charalambous, Robin Hamilton, et al.
Plos One|May 22, 2013
Comparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort studyKavindhran Velen, James J Lewis, Salome Charalambous, et al.
The Journal of Infectious Diseases|November 8, 2017
Designing and Evaluating Interventions to Halt the Transmission of TuberculosisDavid W Dowdy, Alison D Grant, Keertan Dheda, et al.
AIDS (London, England)|November 17, 2010
Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative studyRebecca Lester, Robin Hamilton, Salome Charalambous, et al.
Tropical Medicine & International Health : TM & IH|March 8, 2012
Linking women who test HIV-positive in pregnancy-related services to long-term HIV care and treatment services: a systematic reviewLaura Ferguson, Alison D Grant, Deborah Watson-Jones, et al.
American Journal of Epidemiology|December 19, 2017
Impact of Targeted Tuberculosis Vaccination Among a Mining Population in South Africa: A Model-Based StudySourya Shrestha, Violet Chihota, Richard G White, et al.
Tropical Medicine & International Health : TM & IH|March 4, 2014
Durable HIV RNA resuppression after virologic failure while remaining on a first-line regimen: a cohort studyChristopher J Hoffmann, Salome Charalambous, Alison D Grant, et al.
Pageof 18